Study of Galunisertib in Healthy Participants

Summary

The study involves a single dose of galunisertib taken by mouth by Japanese participants and non-Japanese participants. The study will evaluate the relationship between the effect of the study drug on the electrical activity of the heart, as measured by electrocardiogram (ECG) and how much of the study drug gets into the blood stream and how long it takes the body to remove it. Ths study will last about 42 days for each participant.

Timeline

Start

2016-04

Primary completion

2016-06

Completion

2016-06

Drugs

Indications

No indication recorded.